There were also big increases over the last seven years in injectable soft-tissue filler treatments (78%) and procedures in the laser-light-energy-based category (74%). In 2018, dermatologic surgeons performed 3,491,586 laser-light-energy based procedures; 2,124,921 injectable procedures with neuromodulators; 1,627,628 injectable soft tissue filler treatments.
ASDS members are using energy-based devices predominantly to treat wrinkles and sun damage, with facial redness, excess hair, melasma, scars, acne, tattoos and birthmarks that follow as reasons dermatologic surgeons reach for their lasers, light treatments and other energy-based devices.
Rounding out the most popular procedures among ASDS members are body sculpting, chemical peels, “other rejuvenation,” and vein treatments/sclerotherapy.
Of the 623,557 body sculpting procedures that ASDS members performed in 2018, more than 287,000 were with cryolipolysis. Radiofrequency devices followed at nearly 163,000 procedures performed. Deoxycholic acid demand has increased notably in recent years with 65,735 procedures performed in 2018.
ASDS physicians performed 135,084 sclerotherapy treatments in 2018, which is slightly higher than in recent years but notably less than in 2013 when the survey indicated ASDS doctors performed 223,764 such procedures.
In the “other rejuvenation” category, the survey results suggest microneedling was the most commonly performed rejuvenation option compared to platelet rich plasma (PRP), hair rejuvenation, female rejuvenation and the thread lift. Microneedling increased 45% from 2017 to 2018, with more than 262,000 treatments performed last year.